Loading…
5 companies · GEL, thousands · columns ordered by revenue
| Company | Sector | EBITDA margin · FY 2024 | Percentile | Sector n |
|---|---|---|---|---|
| Universaluri Sameditsin… | Healthcare Services | -2.1% | 22nd pct | 268 |
| Tbilisi City Medical | Healthcare Services | — | no FY data | 268 |
| Alliance Med Service | Healthcare Services | — | no FY data | 268 |
| NNC | Healthcare Services | — | no FY data | 268 |
| Akhali Sameditsino Tsen… | Healthcare Services | — | no FY data | 268 |
Percentile is within each company's own sector across the whole FY2024 cross-section (1st–100th; higher = larger value). Companies with no sector, or no filing for the year, are not ranked.
Only 1 of 5 peers filed FY2024. Switch to FY2019 (5 of 5).
| Ratio — FY 2024 | Universaluri Sameditsin… | Tbilisi City Medical | Alliance Med Service | NNC | Akhali Sameditsino Tsen… |
|---|---|---|---|---|---|
| Margins | |||||
| Gross Margin | 100.0% | — | — | — | — |
| EBITDA Margin | -2.1% | — | — | — | — |
| EBITDAR | -3 | — | — | — | — |
| EBITDAR Margin | -2.1% | — | — | — | — |
| EBIT Margin | -533.4% | — | — | — | — |
| Net Profit Margin | -533.4% | — | — | — | — |
| Operating Expense % of Sales | 102.1% | — | — | — | — |
| Returns | |||||
| Return on Assets (ROA) | -2.2% | — | — | — | — |
| Return on Equity (ROE) | -2.3% | — | — | — | — |
| ROIC [EBIT / Invested Capital] | -2.3% | — | — | — | — |
| Leverage & debt balances | |||||
| Debt-to-Assets | 0.0% | — | — | — | — |
| Debt-to-Equity | 0.00x | — | — | — | — |
| Debt-to-EBITDA | N/A | — | — | — | — |
| Equity-to-Assets | 99.5% | — | — | — | — |
| Net Debt | -4 | — | — | — | — |
| Cash & Equivalents | 4 | — | — | — | — |
| Total Debt | N/A | — | — | — | — |
| Liquidity & working capital | |||||
| Current Ratio | 0.43x | — | — | — | — |
| Quick Ratio | 0.19x | — | — | — | — |
| Cash Ratio | 0.02x | — | — | — | — |
| Total Current Assets | 82 | — | — | — | — |
| Total Current Liabilities | 191 | — | — | — | — |
| Inventory | 46 | — | — | — | — |
| Trade Receivables | 31 | — | — | — | — |
| Trade Payables | 191 | — | — | — | — |
| Net Working Capital | -109 | — | — | — | — |
| Net Working Capital % of Revenue | -73.2% | — | — | — | — |
| Trade Working Capital | -114 | — | — | — | — |
| Trade Working Capital % of Revenue | -75.9% | — | — | — | — |
| Change in Trade Working Capital | N/A | — | — | — | — |
| Turnover & efficiency | |||||
| Inventory Turnover | N/A | — | — | — | — |
| Days Inventory Outstanding (DIO) | N/A | — | — | — | — |
| Receivables Turnover | 4.80x | — | — | — | — |
| Days Sales Outstanding (DSO) | 76.0 | — | — | — | — |
| Payables Turnover | N/A | — | — | — | — |
| Days Payable Outstanding (DPO) | N/A | — | — | — | — |
| Cash Conversion Cycle | 76.0 days | — | — | — | — |
| Asset Turnover | 0.00x | — | — | — | — |
| Cash flow & dividends | |||||
| Operating Cash Flow | 1 | — | — | — | — |
| Free Cash Flow (OCF − Capex proxy) | 1 | — | — | — | — |
| Cash Conversion (OCF / EBITDA) | N/A | — | — | — | — |
| Dividends Declared | 0 | — | — | — | — |
| Dividend Payout Ratio | N/A | — | — | — | — |